C7A.091
Malignant carcinoid tumor of the thymus
Clinical Classification Guidelines
Medical Intelligence & Overview
A malignant carcinoid tumor of the thymus is a rare type of cancer originating in the thymus gland, which is located in the chest. This tumor belongs to the neuroendocrine tumor category, meaning it arises from cells that release hormones into the bloodstream. Due to its malignant nature, it has the potential to spread to other parts of the body if not detected and treated early. Understanding this condition involves knowing its causes, symptoms, diagnostic processes, and available treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting neuroendocrine cells in the thymus Increased cell proliferation due to specific genetic syndromes or familial history Environmental factors or exposures that might influence cell mutation (though these are not well-established for this tumor)
Key Symptoms: Persistent cough or chest discomfort Difficulty breathing or shortness of breath Chest pain that worsens with activity or breathing Unexplained weight loss Feeling of chest heaviness or fullness Feeding or swallowing difficulties in rare cases if the tumor compresses nearby structures Symptoms caused by hormonal secretion, such as flushing or diarrhea, though these are less common
Diagnostic & Treatment
Diagnosis Path: Chest X-ray to identify abnormal masses Computed Tomography (CT) scan provides detailed images of the chest and thymus gland Magnetic Resonance Imaging (MRI) to assess the tumor's extent and involvement with nearby tissues Positron Emission Tomography (PET) scan to identify metastatic activity
Treatment Protocols: Surgical removal - typically the primary treatment, aiming to excise the tumor completely Radiation therapy to target residual cancer cells post-surgery or in cases where surgery isn't feasible Chemotherapy may be used especially if the cancer has spread, but neuroendocrine tumors tend to be resistant to traditional chemotherapy Targeted therapies or hormonal therapy in specific cases to control tumor growth and hormone secretion Supportive care to manage symptoms and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C7A.091 a billable ICD-10 code?
Yes, C7A.091 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C7A.091?
Clinical documentation must specify the nature of Malignant carcinoid tumor of the thymus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference